152 related articles for article (PubMed ID: 7234496)
21. The radiographic spectrum of renal osteodystrophy.
Molpus WM; Pritchard RS; Walker CW; Fitzrandolph RL
Am Fam Physician; 1991 Jan; 43(1):151-8. PubMed ID: 1986484
[TBL] [Abstract][Full Text] [Related]
22. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
[No Abstract] [Full Text] [Related]
23. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
[No Abstract] [Full Text] [Related]
24. [Clinical study of renal osteodystrophy in chronic dialysis patients by means of whole body skeletal scintiphotography (author's transl)].
Kida T; Narita S
Kaku Igaku; 1978 Oct; 15(7):1005-11. PubMed ID: 739671
[No Abstract] [Full Text] [Related]
25. Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
Winney RJ; Bone JM; Anderson TJ; Robson JS
Calcif Tissue Res; 1977 May; 22 Suppl():94-100. PubMed ID: 912593
[No Abstract] [Full Text] [Related]
26. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
[TBL] [Abstract][Full Text] [Related]
27. [Surgical treatment of secondary hyperparathyroidism].
D'Alonzo U
Minerva Med; 1985 Mar; 76(9-10):389-91. PubMed ID: 3982695
[No Abstract] [Full Text] [Related]
28. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
[No Abstract] [Full Text] [Related]
29. Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hyperparathyroidism as the major cause.
de Graaf P; te Velde J; Pauwels EK; Schicht IM; Kleiverda K; de Graeff J
Eur J Nucl Med; 1982; 7(4):152-4. PubMed ID: 7075618
[TBL] [Abstract][Full Text] [Related]
30. Fluoride and dialysis osteodystrophy: results of a double-blind study.
Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
[No Abstract] [Full Text] [Related]
31. Evolution of renal osteodystrophy in patients treated by continuous ambulatory peritoneal dialysis.
El Shahat Y; Jacobs C; Issad B; Rottembourg J; Legrain M
Adv Exp Med Biol; 1982; 151():429-40. PubMed ID: 7180661
[No Abstract] [Full Text] [Related]
32. The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Calderaro V; Oreopoulos DG; Meema HE; Ogilvie R; Husdan H; Khanna R; Quinton C; Murray T; Carmichael D
Proc Eur Dial Transplant Assoc; 1980; 17():533-42. PubMed ID: 6787584
[TBL] [Abstract][Full Text] [Related]
33. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
Massry SG; Goldstein DA; Malluche HH
Kidney Int; 1980 Oct; 18(4):409-18. PubMed ID: 7014981
[No Abstract] [Full Text] [Related]
34. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
Pogglitsch H; Schmidberger H; Gell G
MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
[TBL] [Abstract][Full Text] [Related]
35. [Potentials for the early diagnosis of renal osteodystrophy in patients with chronic kidney failure during treatment by systematic hemodialysis].
Shcherbakova EO; Fekson EG; Cherniakov VL; Shcherbakov VA
Urol Nefrol (Mosk); 1985; (2):58-60. PubMed ID: 3992758
[No Abstract] [Full Text] [Related]
36. Comparison of renal osteodystrophy in patients dialyzed with deionized and non-deionized water.
Posen GA; Gray DG; Jaworski ZF; Couture R; Rashid A
Trans Am Soc Artif Intern Organs; 1972; 18(0):405-11. PubMed ID: 4610968
[No Abstract] [Full Text] [Related]
37. [Calcification in the conjunctiva and cornea in chronic renal insufficiency and haemodialysis (author's transl)].
Hanselmayer H; Pogglitsch H; Schmidberger H
Klin Monbl Augenheilkd; 1974 Jan; 164(1):98-105. PubMed ID: 4825034
[No Abstract] [Full Text] [Related]
38. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
Henderson RG; Russell RG; Ledingham JG; Smith R; Oliver DO; Walton RJ; Small DG; Preston C; Warner GT
Lancet; 1974 Mar; 1(7854):379-84. PubMed ID: 4131033
[No Abstract] [Full Text] [Related]
39. Assessment of osteodystrophy in patients with chronic renal failure.
Brown DJ; Dawborn JK; Thomas DP; Xipell JM
Aust N Z J Med; 1982 Jun; 12(3):250-4. PubMed ID: 6956291
[TBL] [Abstract][Full Text] [Related]
40. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
